Amgen Inc.

Amgen Inc.

3

Total Publications

2

Abstract/Manuscript

1

Oral Presentation

2021 · Abstract/Manuscript · Amgen Inc.

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

2020 · Abstract/Manuscript · Amgen Inc.

Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

2018 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi

Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States